START (South Texas Accelerated Research Therapeutics) announced a joint venture that will open a Phase I clinical trial facility specifically for cancer patients in Fudan University Shanghai Cancer Center (FUSCC). START’s partner in the initiative is Cenova Ventures, an RMB venture capital firm with backing from both national and local government. More details....